Pulmonary Arterial Hypertension Flashcards

1
Q

What is pulmonary hypertension definition?

A

Definition: mPAP ≥ 25mmHg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the 5 different WHO groups of PH

A
  1. Pulmonary Arterial Hypertension (PAH)
  2. Left-heart related
  3. Lung/hypoxia related
  4. CTEPH
  5. Other
    1. Haem disorders, sarcoidosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Explain WHO Group 1 PH

A
  1. Idiopathic or heritable
    1. BMPR2, ALK-1, SMAD9
  2. Associated
    1. Connective Tissue Disorders (scleroderma)
    2. HIV, Schistosomiasis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Explain WHO Group 2 PH and give examples

A

PH with left heart disease

LV sysotlic or diastolic dysfunction, valvular disease, cardiomyopathies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Explain WHO Group 3 PH and give examples

A

PH with lung disease and/or chronic hypoxia

COPD, ILD, OSA, high altitude

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Explain WHO Group 4 PH

A

Pulmonary Hypertension due to blood clots in the lungs

Chronic thromboembolic pulmonary hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Explain WHO Group 5 PH and give examples

A

PH with unclear and multi-factorial mechanisms

Hameatological disorders, sarcoidosis, histiocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

With what equipment is pulmonary hypertension diagnosed and how is this performed

A

Swan-Ganz Catheter - inserted through a vein (femoral, internal jugular, subclavian) follows through to RA, to RV then to the pulmonary artery.

Catheter provides the Mean Pulmonary Artery Pressure - a echocardiogram would provide a systolic blood pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do you differentiate between the different WHO PH Groups

A

PAWP >15mmHg = Group 2 (PH with LHD)

PAWP <15mmHg = Group 1, 3, 4, 5

PAWP = Pulmonary artery wedge pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which WHO Group is treatable and by which therapy

A

Group 1 treated with pulmonary vasodilators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Breifly outline possible pathogenesis of PAH

A

Considered a smooth muscle and endothelial cell disease

Pathogenesis based on a balance of vasodilators/anti-proliferative agents vs vasoconstrictor/proliferative agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

PH is based on balance of vasodilator/anti-proliferative vs vasoconstrictor/proliferative agents. What does an imbalance of these factors lead to? (4)

A
  1. Vascular remodelling
  2. Increased vascular tone
  3. Prothrombotic abnormalities
  4. Autoimmunity

Ulitmately = Excessive vasoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

IPAH has a genetic aetiology too. There is belief that there is a two-hit hypothesis associated with PAH. Explain what is meant by this.

A

Patient can have a mutation making them genetically susceptible to PAH.

They will not display symptoms until another hit (virus, inflammation, hypoxia, drugs) occurs (repeated insults)

BMPR2, SMAD9, ALK1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

There has been interest into redfining the definition for pulmonary hypertension as the current definition (mPAP ≥ _____) was chosen arbitrarily. Statsitical methods have shown that having mPAP of 20 mmHg is abnormal and yet we don’t define this as pulmonary HTN. Data also shows that pressures of 19-24 mmHg show poor _____ and _____ chance of ______ compared to normal (18mmHg). There have also been cases wher pathology showed signs of remodelling at mPAP 22mmHg

A

There has been interest into redfining the definition for pulmonary hypertension as the current definition (mPAP ≥ 25) was chosen arbitrarily. Statsitical methods have shown that having mPAP of 20 mmHg is abnormal and yet we don’t define this as pulmonary HTN. Data also shows that pressures of 19-24 mmHg show poor prognosis and decreased chance of survival compared to normal (18mmHg). There have also been cases wher pathology showed signs of remodelling at mPAP 22mmHg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the consequences of pulmonary artery hypertension

A

Raised pulmonary artery pressure

Leads to vascular proliferation and arterial wall thickening.

Vasoconstriction and in situ thrombosis also occurs

There is ↑pulmonary vascular resistance

Leads to RVH and dilatation resulting in RVF

40% mortality per year if untreated - there is increased wall thickening due to Laplace’s law (T = (P x r)/2h)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe a characteristic feature of group I pulmonary hypertension (PAH)

A

Plexiform lesions (capillary like network)

17
Q

Differentiate between IPAH and PH with emphysema

A

IPAH characterised by proliferating vessels, smooth muscle hypertrophy

PH with emphysema - there is destruction of vessels

Implications in lung studies looking at PVR as primary end point as there is no continuity between the right side of heart and pulmonary artery in terms of pressure. The structural changes in emphysema negates pressure measurments

18
Q

What determines the pulmonary vascular resistance

A

The small vessels of the lungs (capillaries)

19
Q

Define Pulmonary hypertension

A

mPAP ≥ 25 mmHg

20
Q

Define pulmonary arterial hypertension

A

mPAP ≥ 25 mmHg

PCWP 15 mmHg

PVR ≥ 3 WU

21
Q

Define pulmonary venous hypertension (post-capillary HTN)

A

mPAP ≥ 25 mmHg

PCWP > 15 mmHg

22
Q

Raised PVR leads to what cardiac consequence?

A

Raised PVR = Right Ventricle dysfunction

The ability of RV to cope determines the survival of the patient

IPAH RV have more collagen deposits compared to a congenital cardiomypoathy - reason why IPAH patients die more compared to congenital heart disease

23
Q

What is the consequence of a failing right ventricle?

A
  1. ↓Oxygen supply
    1. ↓Coronary perfusion pressure
    2. ↑Oxygen demand
  2. ↓Cardiac Output
    1. ↑RV distension
    2. ↓LV filling
24
Q

The characteristic symptoms of PH present late: (6)

A

Tachypnoea/Arrythmia

Raised JVP (a wave or v wave)

RV heave

Loud 2nd heart sound

RHF

Hepatomegaly

25
Q

Describe the 4 WHO Functional Classes of PH (symptoms)

A
  • Class I
    • Symptoms do not limit phycial activity
  • Class II
    • Comfortqable at rest, symptoms with ordinary activity
  • Class III
    • Comfortable at rest, symptoms with minimal activity
  • Class IV
    • Unable to carry out activity - symptoms at rest (RHF)
26
Q

A _____ WHO functional class indicates severity of disease. Untreated median survival of PH is _____ years (2011). Mortality is subtype dependent and survival is dependent on the _____ _____ ability to adapt to the high pressures.

A

A higher WHO functional class indicates severity of disease. Untreated median survival of PH is 7 years (2011). Mortality is subtype dependent and survival is dependent on the Right ventircle’s ability to adapt to the high pressures.

27
Q

What is the first-line screening method for PAH

A

Estimated systolic PAP on an echocardiogram

  • Derived from tricuspid regurgitant velocity*
  • TR Velocity 2.8 m/s*
  • Insufficient TR and poor echo windows lead to inability to estimate TR/sPAP*
28
Q

Name some clinical investigations to help diagnose PH

A
  • TFTs and Autoimmune screen
  • BNP (ventricular myocytes)
  • ECG
    • RVH ± strain pattern
    • Arrythmias
  • CXR
    • Cardiomegaly (RA border)
    • Large, dilated proximal pulmonary arteries
  • Echocardiogram
    • Estimated sPAP
    • TR Velocity 2.8 m/s
  • VQ
  • CTPA
29
Q

Describe the findings seen on a CT

A

Dilated central pulmonary artery

RV chamber dimensions

Septal shift

Mosaicism (in lung, neovascularisation)

30
Q

Pulmonary Veno-Occlusive Disease (PVOD) is a rare form of pulmonary HTN, featuring blockade of small veins in the lung. What is the triad for PVOD

A
  1. Interlobular septal thickening
  2. Pleural Effusions
  3. ?Nodes
31
Q

Describe the management of PAH

A
  1. MDT approach
    1. Cardioresp consultants
    2. Specialist nurses
    3. Pharmacists
    4. Radiologists
  2. General Measures
    1. Warfarin
    2. Oxygen
    3. Diuretics (volume control)
  3. Pharmacology
    1. CCBs
    2. ET-1R antagonists (severe SE, only in severe)
    3. Prostanoid therapy (good, but SE, CI)
    4. PDE inhbitors (sildenafil)
  4. Lung Transplant
32
Q

Name some determinants of prognosis in PAH

A

RV failure

Symptom progression

Syncope

WHO FC

6MWT

Exercise Test

BMP levels

Echocardioaphic findings

Haemodynamics